Delivering Value To Those We Serve

Overview

Recent News

Date Title and Summary
Toggle Summary Assertio Therapeutics Announces FDA Notification of Acceptance for Filing of 505(b)(2) NDA for Long-acting Cosyntropin
Company Anticipates Potential Market Launch by Early 2020 LAKE FOREST, Ill. , Feb. 19, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that it has received notification of acceptance for filing from the U.S. Food and Drug Administration ( FDA ) for its 505(b)(2)
Toggle Summary Assertio Therapeutics Announces Appointment of Heather L. Mason to Board of Directors
LAKE FOREST, Ill. , Feb. 19, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that Heather L. Mason has been appointed to the Company’s Board of Directors. Ms. Mason is a former executive vice president of Abbott Laboratories .
Toggle Summary Assertio Therapeutics Announces Amendment of its Senior Secured Credit Facility
Agreement Provides Greater Financial Flexibility as Company Continues to Reduce Debt LAKE FOREST, Ill. , Jan. 09, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that it has amended its Senior Secured Credit Facility, replacing the previous fixed adjusted EBITDA

Upcoming Events

There are currently no events to display.
Presentations

Recent SEC Filings

Filing date Description Form Filing Group View

Report of unscheduled material events or corporate event

8-K
Current Reports
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

An amendment to the SC 13G filing

SC 13G/A
3,4,5
View HTML

Annual filing director officer or owner of more than ten percent.

5
3,4,5
View HTML

IR Contact

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com
 

Independent Registered Public Accounting Firm

Ernst & Young LLP
Palo Alto, CA
 

Investor Relations Contact

John B. Thomas
SVP, Investor Relations & Corporate Communications
jthomas@assertiotx.com